Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HSDT Helius Medical Technologies	$0.33 -8.4%	$3.33	$0.30 ▼ $24.00	$175K	1.12	1.50 million shs	7.92 million shs
NDRA ENDRA Life Sciences	$3.19 -0.6%	$3.82	$2.90 ▼ $210.00	$2.36M	-0.21	141,176 shs	82,578 shs
NUWE Nuwellis	$0.27 -4.2%	$0.79	$0.21 ▼ $8.23	$1.17M	0.48	3.37 million shs	29.07 million shs
TIVC Tivic Health Systems	$3.80 -2.1%	$4.36	$2.43 ▼ $16.08	$3.34M	1.99	648,937 shs	9,513 shs

2025 Gold Forecast: A Perfect Storm for Demand

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HSDT Helius Medical Technologies	0.00%	-35.17%	-92.11%	-94.43%	-97.74%
NDRA ENDRA Life Sciences	0.00%	-7.54%	+2.57%	-28.95%	-99.97%
NUWE Nuwellis	0.00%	-4.26%	-71.21%	-76.56%	-96.36%
TIVC Tivic Health Systems	0.00%	+2.43%	-7.54%	+11.44%	-42.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HSDT Helius Medical Technologies	0.2527 of 5 stars	0.0	2.0	0.0	0.0	1.1	0.8	0.6
NDRA ENDRA Life Sciences	2.9472 of 5 stars	3.5	4.0	0.0	0.0	2.8	0.0	1.3
NUWE Nuwellis	2.5972 of 5 stars	3.5	5.0	0.0	0.0	0.6	0.0	1.3
TIVC Tivic Health Systems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HSDT Helius Medical Technologies	2.00	Hold	N/A	N/A
NDRA ENDRA Life Sciences	3.00	Buy	$50.00	1,467.40% Upside
NUWE Nuwellis	3.00	Buy	$17.00	6,262.28% Upside
TIVC Tivic Health Systems	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest TIVC, NUWE, NDRA, and HSDT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/21/2025	NDRA ENDRA Life Sciences	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$75.00 ➝ $50.00

(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HSDT Helius Medical Technologies	$520K	0.34	N/A	N/A	$4.26 per share	0.08
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$4.77 per share	N/A
NUWE Nuwellis	$8.74M	0.13	N/A	N/A	$1.49 per share	0.18
TIVC Tivic Health Systems	$780K	4.29	N/A	N/A	$4.55 per share	0.84

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HSDT Helius Medical Technologies	-$11.74M	-$47.53	N/A	∞	N/A	-3,010.14%	-418.82%	-243.54%	8/11/2025 (Estimated)
NDRA ENDRA Life Sciences	-$11.51M	-$172.04	N/A	N/A	N/A	N/A	-140.96%	-106.14%	8/13/2025 (Estimated)
NUWE Nuwellis	-$11.16M	-$18.24	N/A	N/A	N/A	-112.09%	-655.31%	-141.83%	8/12/2025 (Estimated)
TIVC Tivic Health Systems	N/A	N/A	0.00	∞	N/A	-4.07%	-0.67%	-0.57%	8/13/2025 (Estimated)

Latest TIVC, NUWE, NDRA, and HSDT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	TIVC Tivic Health Systems	N/A	-$2.52	N/A	-$2.52	N/A	$0.07 million
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
5/1/2025	Q1 2025	HSDT Helius Medical Technologies	-$0.58	-$0.51	+$0.07	-$0.51	N/A	$0.05 million
3/31/2025	Q4 2024	NDRA ENDRA Life Sciences	-$4.10	-$9.40	-$5.30	-$20.78	N/A	N/A
3/25/2025	Q4 2024	HSDT Helius Medical Technologies	-$14.10	-$15.45	-$1.35	-$1.03	$0.10 million	$0.15 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HSDT Helius Medical Technologies	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
TIVC Tivic Health Systems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HSDT Helius Medical Technologies	N/A	1.69	1.13
NDRA ENDRA Life Sciences	N/A	3.85	3.85
NUWE Nuwellis	N/A	2.23	1.59
TIVC Tivic Health Systems	N/A	1.70	1.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HSDT Helius Medical Technologies	18.63%
NDRA ENDRA Life Sciences	1.19%
NUWE Nuwellis	3.13%
TIVC Tivic Health Systems	4.25%

Insider Ownership

Company	Insider Ownership
HSDT Helius Medical Technologies	17.90%
NDRA ENDRA Life Sciences	0.04%
NUWE Nuwellis	2.60%
TIVC Tivic Health Systems	0.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HSDT Helius Medical Technologies	30	530,000	433,000	Not Optionable
NDRA ENDRA Life Sciences	20	740,000	738,000	Not Optionable
NUWE Nuwellis	70	4.37 million	4.26 million	Not Optionable
TIVC Tivic Health Systems	10	880,000	874,000	Not Optionable

TIVC, NUWE, NDRA, and HSDT Headlines

Recent News About These Companies

Tivic Health sets new deadlines for stockholder proposals

May 21, 2025 | investing.com

Tivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call Transcript

May 17, 2025 | msn.com

Tivic Health’s Strategic Shift: Earnings Call Insights

May 16, 2025 | tipranks.com

Tivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioning

May 16, 2025 | msn.com

Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript

May 15, 2025 | seekingalpha.com

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 15, 2025 | businesswire.com

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

May 14, 2025 | finance.yahoo.com

Tivic adds new vagus nerve stim patent

May 13, 2025 | massdevice.com

Tivic Expands VNS Intellectual Property Portfolio

May 13, 2025 | businesswire.com

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

May 9, 2025 | businesswire.com

Tivic Health reports White House briefings, FDA meetings on product applications

April 23, 2025 | markets.businessinsider.com

Tivic Health Systems Stock Is On Fire Today: What's Going On?

April 22, 2025 | benzinga.com

Tivic Health Systems Shares Rise on White House and FDA Briefings

April 22, 2025 | marketwatch.com

Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish

April 22, 2025 | msn.com

Tivic Health shares soar on defense application interest

April 22, 2025 | investing.com

Tivic Health exercises licensing option for Entolimod

April 17, 2025 | markets.businessinsider.com

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

April 15, 2025 | businesswire.com

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

April 10, 2025 | businesswire.com

Tivic Health Systems, Inc. (NASDAQ:TIVC) Q4 2024 Earnings Call Transcript

March 26, 2025 | msn.com

Tivic Health Systems’ Earnings Call Highlights Strategic Shift

March 24, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TIVC, NUWE, NDRA, and HSDT Company Descriptions

Helius Medical Technologies NASDAQ:HSDT

$0.33 -0.03 (-8.41%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$0.32 -0.01 (-2.42%)

As of 06/20/2025 07:59 PM Eastern

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

ENDRA Life Sciences NASDAQ:NDRA

$3.24 +0.03 (+0.81%)

As of 06/20/2025 04:00 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Nuwellis NASDAQ:NUWE

$0.27 -0.01 (-4.20%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$0.29 +0.02 (+8.53%)

As of 06/20/2025 07:59 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Tivic Health Systems NASDAQ:TIVC

$3.80 -0.08 (-2.06%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$3.92 +0.12 (+3.26%)

As of 06/20/2025 05:54 PM Eastern

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time